📰 Stacy Coen News
Stacy Coen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stacy Coen. Real-time updates on events, politics, business and more.
February 7, 2024
On February 5, 2024, Stacy Coen, SVP & CHIEF BUSINESS OFFICER of Immunogen Inc, executed a sale of 4,583 shares of the company.
November 18, 2023
In a notable insider transaction, Stacy Coen, the Senior Vice President & Chief Business Officer of Immunogen Inc (NASDAQ:IMGN), sold 108,609 shares of the company on November 17, 2023.
June 14, 2022
ImmunoGen and OBT have entered into a multi-year research collaboration to develop new antibody-drug conjugates (ADCs) to treat cancers.
June 14, 2022
Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based therapies, today announced a multi-year collaboration to research, develop and commercialize novel, first-in-class ADCs with ImmunoGen (IMGN), a leader in the expanding field of ...
June 13, 2022
/PRNewswire/ -- Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based...
August 7, 2021
FibroBiologics Announces Inaugural Board of Directors - read this article along with other careers information, tips and advice on BioSpace